Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
PW Medtech Group Ltd. ( (HK:1358) ) has provided an update.
PW Medtech Group Ltd. announced the voluntary suspension of the review process for the subsequent listing of its subsidiary, Sichuan Ruijian Medical, on the Beijing Stock Exchange. This decision was made due to the impending expiration of the financial statement cut-off date, with the review status now adjusted to suspension. The listing process remains ongoing, subject to market conditions and regulatory approvals, and shares of Sichuan Ruijian Medical remain suspended from trading on the NEEQs.
The most recent analyst rating on (HK:1358) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on PW Medtech Group Ltd. stock, see the HK:1358 Stock Forecast page.
More about PW Medtech Group Ltd.
PW Medtech Group Ltd. is a company incorporated in the Cayman Islands, operating in the medical technology industry. It focuses on providing medical products and services, with a market interest in expanding its operations and listings in various stock exchanges.
Average Trading Volume: 1,791,417
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.34B
Find detailed analytics on 1358 stock on TipRanks’ Stock Analysis page.